Humans have a remarkable ability to recognize faces despite variations in appearance. Regardless of aging, changes in weight or facial hair, or even cosmetic surgery, we can usually—but not ...

Eddie Possehl is a dynamic and driven writer/director with a passion for the written word and all things film, television, comics, and games. His passion for storytelling led him to establish his own ...

Charli XCX recently opened up about beauty, self-image, and her thoughts on cosmetic surgery. In a new interview for Vanity Fair, the 33-year-old songwriter revealed that she frequently contemplates ...

The fresh capital will be used to build and test Morphing Machines’ first chip, strengthen its product, and expand its team to over 90 members from 50 currently Morphing Machines has developed a ...

The Minnesota Vikings were willing to risk it all on JJ McCarthy. Five weeks into the 2025 NFL season, that risk may have already backfired. McCarthy could miss the next few weeks with an ankle injury ...

These days, celebrities are accused of having some kind of cosmetic treatment or plastic surgery done all the time. But not many expected Bradley Cooper to be dealing with these accusations. Until now ...

Before taxi tests in 2026, the aircraft with Airbus' Extra Performance Wing is slated to undergo ground vibration and wing-loading tests this year. Credit: Airbus UpNext Under the Extra Performance ...

Responsive materials that morph and adapt like biological systems are non-trivial to design and manufacture. Researchers developed a co-design framework that unites AI, physics, and 3D printing into ...

The US National Institute of Standards and Technology (NIST) has published new guidelines it claims will help organizations optimize their efforts to detect face morphing software. Face morphing is a ...

The National Institute of Standards and Technology (NIST) has released guidelines that aim to help in the detection of face morphing attacks and biometric identity fraud. A post from NIST introduces ...

TG Therapeutics, Inc.'s BRIUMVI saw Q1 2025 revenue surge 137% YoY to $119.7M, driven by strong U.S. growth. A subcutaneous version of TGTX's BRIUMVI is in phase 1 trials, with late-stage development ...